GlaxoSmithKline Flixotide Evohaler 50 mcg 120 Doses is a medicine registered with the Saudi Food and Drug Authority. It contains the active ingredient Fluticasone Propionate, and its pharmaceutical form is suspension for steam inhalation. This medicine is available on prescription only.
Medicine Details
- Registered Trade Name: FLIXOTIDE 50 MCG EVOHALER
- Active Ingredient: Fluticasone Propionate
- Pharmaceutical Form: Suspension for Steam Inhalation
- Route of Administration: Inhalation
- Marketing Authorisation Holder: GLAXO SAUDI ARABIA (Saudi Arabia)
- ATC Classification Code: R03BA05
Prescription Requirement
This medicine is dispensed only against a valid prescription from a licensed doctor. When ordering from the store, upload a prescription image for the pharmacist to review before preparing the order. The dose and duration of use are determined solely by the treating doctor.
Storage
Store at room temperature not exceeding 30 degrees Celsius, protected from light. Keep out of reach of children.
Registration Information
Registered with the Saudi Food and Drug Authority under number 0601221577.
The information above provides identification details from the Saudi Food and Drug Authority register and does not replace the treating doctor's instructions, the patient leaflet, or consultation with a pharmacist.